Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review

Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are currently being investigated in trials as potential therapy for coronavirus disease 2019 (COVID-19). A thorough understanding of the current body of evidence regarding the ben...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cochrane database of systematic reviews Ročník 7; s. CD013600
Hlavní autoři:	Piechotta, Vanessa, Chai, Khai Li, Valk, Sarah J, Doree, Carolyn, Monsef, Ina, Wood, Erica M, Lamikanra, Abigail, Kimber, Catherine, McQuilten, Zoe, So-Osman, Cynthia, Estcourt, Lise J, Skoetz, Nicole
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 10.07.2020
Témata:	Betacoronavirus - immunology Cause of Death Coronavirus Infections - immunology Coronavirus Infections - mortality Coronavirus Infections - therapy COVID-19 COVID-19 Serotherapy Early Termination of Clinical Trials Humans Immunization, Passive - adverse effects Immunization, Passive - methods Immunization, Passive - mortality Immunization, Passive - statistics & numerical data Non-Randomized Controlled Trials as Topic - mortality Non-Randomized Controlled Trials as Topic - statistics & numerical data Pandemics Pneumonia, Viral - immunology Pneumonia, Viral - mortality Pneumonia, Viral - therapy Randomized Controlled Trials as Topic - statistics & numerical data Respiration, Artificial - statistics & numerical data SARS-CoV-2 Selection Bias Severity of Illness Index Treatment Outcome
ISSN:	1469-493X, 1469-493X
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!